Journal of International Oncology››2014,Vol. 41››Issue (12): 890-893.doi:10.3760/cma.j.issn.1673-422X.2014.12.004
Previous ArticlesNext Articles
Online:
2014-12-24Published:
2015-02-02Contact:
Wang Yu, Email: wangyu11122@sina.comYAN Lei-Lei, PENG Jia-Yuan, WANG Yu. Role of zincfinger protein X-linked in the development of neoplasms[J]. Journal of International Oncology, 2014, 41(12): 890-893.
[1] Miller J, McLachlan AD, Klug A. Repetitive zincbinding domains in the protein transcription factor IIIA from Xenopus oocytes[J]. EMBO J, 1985, 4(6): 16091614. [2] Hoovers JM, Mannens M, John R, et al. Highresolution localization of 69 potential human zinc finger protein genes: a number are clustered[J]. Genomics, 1992, 12(2): 254263. [3] Chandrasekharan S, Kumar S, Valley CM, et al. Proprietary science, open science and the role of patent disclosure: the case of zincfinger proteins[J]. Nat biotechnol, 2009, 27(2): 140144. [4] Schnidar H, Eberl M, Klingler S, et al. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway[J]. Cancer Res, 2009, 69(4): 12841292. [5] Poloumienko A. Cloning and comparative analysis of the bovine, porcine, and equine sex chromosome genes ZFX and ZFY[J]. Genome, 2004, 47(1): 7483. [6] SchneiderGdicke A, BeerRomero P, Brown LG, et al. Putative transcription activator with alternative isoforms encoded by human ZFX gene[J]. Nature, 1989, 342(6250): 708711. [7] Fortunel NO, Otu HH, Ng HH, et al. Comment on " ′Stemness′: transcriptional profiling of embryonic and adult stem cells" and "a stem cell molecular signature"[J]. Science, 2003, 302(5644): 393393. [8] Huang D, Gao Q, Guo L, et al. Isolation and identification of cancer stemlike cells in esophageal carcinoma cell lines[J]. Stem Cells Dev, 2009, 18(3): 465474. [9] RamalhoSantos M, Yoon S, Matsuzaki Y, et al. "Stemness": transcriptional profiling of embryonic and adult stem cells[J]. Science, 2002, 298(5593): 597600. [10] GalanCaridad JM, Harel S, Arenzana TL, et al. Zfx controls the selfrenewal of embryonic and hematopoietic stem cells[J]. Cell, 2007, 129(2): 345357. [11] Ivanova N, Dobrin R, Lu R, et al. Dissecting selfrenewal in stem cells with RNA interference[J]. Nature, 2006, 442(7102): 533538. [12] Zhou Y, Su Z, Huang Y,et al. The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251[J]. J Exp Clin Cancer Res, 2011, 30: 114. [13] Zhu Z, Li K, Xu D, et al. ZFX regulates glioma cell proliferation and survival in vitro and in vivo[J]. J Neurooncol, 2013, 112(1): 1725. [14] Wang J, Wang H, Li Z, et al. cMyc is required for maintenance of glioma cancer stem cells[J]. PLoS One, 2008, 3(11): e3769. [15] Hendruschk S, Wiedemuth R, Aigner A, et al. RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo[J]. Neuro Oncol, 2011, 13(10): 10741089. [16] Komata T, Kanzawa T, Takeuchi H, et al. Antitumour effect of cyclindependent kinase inhibitors (p16INK4A, p18INK4C, p19INK4D, p21WAF1/CIP1 and p27KIP1) on malignant glioma cells[J]. Br J Cancer, 2003, 88(8): 12771280. [17] Fang X, Huang Z, Zhou W, et al. The zinc finger transcription factor ZFX is required for maintaining the tumorigenic potential of glioblastoma stem cells[J]. Stem Cells, 2014, 32(8): 20332047. [18] Zheng H, Ying H, Yan H, et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation[J]. Nature, 2008, 455(7216): 11291133. [19] Radke J, Bortolussi G, Pagenstecher A. Akt and cMyc induce stemcell markers in mature primary p53-/- astrocytes and render these cells gliomagenic in the brain of immunocompetent mice[J]. PloS one, 2013, 8(2): e56691. [20] Li K, Zhu ZC, Liu YJ, et al. ZFX knockdown inhibits growth and migration of nonsmall cell lung carcinoma cell line H1299[J]. Int J Exp Pathol, 2013, 6(11): 24602467. [21] Namls HM, MezaZepeda LA, Bary T, et al. Modulation of the osteosarcoma expression phenotype by microRNAs[J]. PLoS One, 2012, 7(10): e48086. [22] Guled M, Lahti L, Lindholm PM, et al. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma A miRNA microarray analysis[J]. Genes Chromosomes Cancer, 2009, 48(7): 615623. [23] Zha W, Cao L, Shen Y, et al. Roles of Mir144ZFX Pathway in Growth Regulation of NonSmallCell Lung Cancer[J]. PLoS One, 2013, 8(9): e74175. [24] Akiyoshi S, Fukagawa T, Ueo H, et al. Clinical significance of miR144ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases[J]. Br J Cancer, 2012, 107(8): 13451353. [25] Wu S, Lao XY, Sun TT, et al. Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo downregulating the ERKMAPK pathway[J]. Cancer Lett, 2013, 337(2): 293300. [26] Lai KP, Chen J, He M, et al. Overexpression of ZFX confers selfrenewal and chemoresistance properties in hepatocellular carcinoma[J]. Int J Cancer, 2014, 135(8): 17901799. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[5] | Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[6] | Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[7] | Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[8] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[9] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[11] | Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||